Table 3.

Anxiety and depression disorders in the intention-to-treat population.

	Control		APAD
	n	%	n	%	p
Baseline (T0)
Anxiety					0.662
Absence (<7)	0	0.00	0	0.00
Suspected (8–10)	2	1.12	3	1.67
Confirmed (>10)	176	98.88	177	98.33
Mean anxiety (SD)	11.85 (2.56)		11.92(2.69)
Depression					0.368
Absence (<7)	0	0.00	2	1.11
Suspected (8–10)	70	39.33	71	39.44
Confirmed (>10)	108	60.67	107	59.44
Mean depression (SD)	18.93 (3.34)		18.78 (3.54)
End of chemotherapy (T1)
Anxiety					0.974
Absence (<7)	0	0.00	0	0.00
Suspected (8–10)	1	0.64	1	0.67
Confirmed (>10)	156	99.36	149	99.33
Mean anxiety (SD)	12.29 (3.21)		11.99 (3.03)
Depression					0.163
Absence (<7)	0	0.00	3	2.00
Suspected (8–10)	55	35.03	57	38.00
Confirmed (>10)	102	64.97	90	60.00
Mean depression (SD)	20.25 (3.26)		20.46 (3.22)
End of radiotherapy (T2)
Anxiety
Absence (<7)	0	0.00	0	0.00
Suspected (8–10)	0	0.00	0	0.00
Confirmed (>10)	147	100.00	142	100.00
Mean anxiety (SD)	11.69 (3.04)		11.97 (3.04)
Depression					0.576
Absence (<7)	1	0.68	1	0.70
Suspected (8–10)	68	46.26	57	40.14
Confirmed (>10)	78	53.06	84	59.15
Mean depression (SD)	20.38 (3.06)		20.08 (3.34)
1 year after inclusion (T3)
Anxiety					0.367
Absence (<7)	0	0.00	1	0.81
Suspected (8–10)	1	0.77	0	0.00
Confirmed (>10)	129	99.23	123	99.19
Mean anxiety (SD)	11.85 (2.42)		11.81 (3.11)
Depression					0.052
Absence (<7)	0	0.00	2	1.61
Suspected (8–10)	43	33.08	55	44.35
Confirmed (>10)	87	66.92	67	54.03
Mean depression (SD)	20.26 (2.87)		19.87 (3.62)